RP

Rajdeep Paul

Active Director Director DIN 09460872
DIN 09460872 First appointment Jan 2022 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2022
Shareholding value •••• Premium profile

About Rajdeep Paul

Data last updated:

Rajdeep Paul is a Director at Mrira Accretion Pharma Private Limited (since 2022). The company operates in Chemicals. Mrira Accretion Pharma Private Limited reported revenue of ₹37 Lakh (FY 2025).

DIN 09460872
Primary Designation Director
Industry Chemicals
First Appointment 07 Jan 2022
Oldest Company Age 4 yrs
Largest company Mrira Accretion Pharma Private Limited · ₹37 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director07 Jan 20222022₹37 Lakh (FY 2025)Active

Board colleagues of Rajdeep Paul

NameDINCompanyDesignation
Nandita Das09460871Mrira Accretion Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Mrira Accretion Pharma Private Limited
Premium access

Shareholding and investment profile for Rajdeep Paul

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rajdeep Paul

Rajdeep Paul currently holds 1 directorship: Mrira Accretion Pharma Private Limited (Director, since 07 Jan 2022, revenue ₹37 Lakh (FY 2025)).

Rajdeep Paul was first appointed on 07 Jan 2022 as Director at Mrira Accretion Pharma Private Limited.

The current boards of Rajdeep Paul's companies include Nandita Das (Mrira Accretion Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available